• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Lexicon Pharmaceuticals Inc

+ Add to Watchlist

LX3:GR

0.694 EUR 0.047 6.34%

As of 15:14:48 ET on 12/23/2014.

Snapshot for Lexicon Pharmaceuticals Inc (LX3)

Open: 0.726 Day's Range: 0.685 - 0.740 Volume: 800
Previous Close: 0.741 52wk Range: 0.660 - 1.555 1-Yr Rtn: -47.82%

Stock Chart for LX3

No chart data available.
  • LX3:GR 0.740
  • 1D
  • 1M
  • 1Y
0.741
Interactive LX3 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LX3

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.1970
Est. PEG Ratio -
Market Cap (M EUR) 495.40
Shares Outstanding (M) 713.84
30 Day Average Volume 2,030
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LX3

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for LX3

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company researches treatments for diabetes and obesity, cardiovascular disease, psychiatric and neurological disorders, cancer, immune system disorders, and ophthalmic disease.

Lonnel CoatsPresident/CEOBrian P ZambrowiczExec VP/Chief Scientific Ofcr
Jeffrey L WadeExec VP:Corporate Dev/CFOPablo LapuertaExec VP:Clinical Dev
More Company Profile & Key Executives for LX3

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil